Scientists at La Jolla Institute for Immunology (LJI) have found that people with Parkinson's disease have a clear "genetic signature" of the disease in their memory T cells. The scientists hope that targeting these genes ...
Mar 21, 2022
0
141
As the world enters a third year of pandemic-related uncertainties, one thing does seem certain: The SARS-CoV-2 virus mutates and keeps us on our toes.
Jan 13, 2022
0
7
In a world-first, researchers at Newcastle University have found that the brains of infants who sadly passed away with an extremely rare genetic condition, Krabbe disease, have similar changes to those seen in two age-related ...
Jan 10, 2022
0
39
(HealthDay)—COVID-19 vaccination is associated with a smaller reduction in transmission of the Delta variant compared with the alpha variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to ...
Jan 7, 2022
0
48
How can we shift from a state of inattentiveness to one of highest attention? The locus coeruleus, literally the "blue spot," is a tiny cluster of cells at the base of the brain. As the main source of the neurotransmitter ...
Jan 7, 2022
0
157
The SARS-CoV-2 Alpha (B.1.1.7) variant mutated to evade our 'innate immune system', helping establish it as the world's first 'Variant of Concern', finds a new study led by researchers at UCL and the Quantitative Biosciences ...
Dec 23, 2021
0
498
Biomedical scientists at the University of California, Riverside, propose a way for drugs to be more effective against inflammatory bowel disease, or IBD, in which the intestine undergoes inflammation.
Dec 18, 2021
0
118
A molecule that shows promise in preventing Parkinson's disease has been refined by scientists at the University of Bath in the UK, and has the potential to be developed into a drug to treat the deadly neurodegenerative disease.
Dec 9, 2021
0
290
Whether or not someone develops Parkinson's disease may be a game of nanometers.
Dec 8, 2021
0
80
Even when at rest, the brain is never truly quiet.
Nov 30, 2021
0
472
